Immunopathogenesis and therapy of cutaneous T cell lymphoma
J. Clin. Invest. Ellen J. Kim, et al. 115:798 doi:10.1172/JCI24826 [Go to this article.]

Figure 4
Consequences of malignant T cell cytokine production. In MF/SS, the malignant T cell (CD4⁺/CLA⁺/CCR4⁺) produces the cytokines IL-4, IL-5, and IL-10 that result in a Th2 predominance and subsequent multiple abnormalities in cellular immunity.